HIV And Esophageal Cancer In Mozambique: What Can We Learn?

  • Atílio Morais Thoracic surgery service, Maputo Central Hospital, Mozambique; Mozambique Institute for Health Education and Research (MIHER), Maputo, Mozambique; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique
  • Matchecane Cossa Thoracic surgery service, Maputo Central Hospital, Mozambique; Mozambique Institute for Health Education and Research (MIHER), Maputo, Mozambique
  • Abdul Pardival Thoracic surgery service, Maputo Central Hospital, Mozambique
  • Jessica Rodrigues Group of Epidemiology, Results, Economy and Management in Oncology, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto. CCC) & RISE@CI-IPOP (Health Research Network), Porto, Portugal http://orcid.org/0000-0002-1571-5151
  • Adriano Tivane Thoracic surgery service, Maputo Central Hospital, Mozambique
  • Pires Germano Thoracic surgery service, Maputo Central Hospital, Mozambique
  • Emilia Noormahomed Mozambique Institute for Health Education and Research (MIHER), Maputo, Mozambique; Department of Microbiology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique; Department of Medicine, Infectious Disease Division, School of Medicine, University of California, San Diego, California, USA
  • Maria José Bento Group of Epidemiology, Results, Economy and Management in Oncology, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto. CCC) & RISE@CI-IPOP (Health Research Network), Porto, Portugal; Department of Population Studies, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal http://orcid.org/0000-0002-7690-9830
  • Lúcio Lara Santos Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto. CCC) & RISE@CI-IPOP (Health Research Network), Porto, Portugal; Surgical Oncology Department – Portuguese Institute of Oncology, Porto, Portugal; Department of Anatomy, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal and School of Medicine and Biomedical Sciences at Fernando Pessoa University, Porto, Portugal http://orcid.org/0000-0002-0521-5655

Abstract

Esophageal cancer (EC) is a common cancer in Mozambique, with esophageal squamous cell carcinomas (ESCC) being the most frequent subtype of this cancer. Little is known about the impact of the human immunodeficiency virus (HIV) on this pathology. The main goal of this study was to assess the association between EC and HIV infection.


Methods: A case-control study was conducted, in 2018, at Maputo Central Hospital, Mozambique (MCH).  Consenting adults were eligible for inclusion. Patients with ESCC who underwent HIV testing constituted the case groups. Controls were selected from patients with surgical benign conditions, and they were matched by sex and age. Chi-square or Fisher’s exact tests were used to evaluate the association between two categorical variables. Comparisons between groups were performed, using independent samples t-tests or Mann–Whitney tests for continuous variables. Odds Ratio (OR), and the corresponding 95% confidence interval (CI) were computed using non-conditional logistic regression. A p-value < 0.05 was considered significant.


Results: During the study period, 92 cases and 92 controls were enrolled into the study. 67.4% of the cases were female. The median age of cases and controls was 57 (35-83) and 52 (35-85) years, respectively.


HIV-positive diagnosis significantly increased the odds of developing EC, mainly in females (OR=4.81; 95% CI: 2.24–10.32; p<0.001), but the same did not occur in males (OR=2.26; 95% CI: 0.80–6.36; p=0.123).


Conclusion: Esophageal cancer and human immunodeficiency virus are common in Mozambique.  HIV infection is a potential risk factor for ESCC mainly in the female gender. Patients with HIV and other risk factors such as exposure to domestic or tobacco smoke should be educated and followed up for an early diagnosis of esophageal cancer.

Downloads

Download data is not yet available.

References

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424
2. Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020 Dec;13(6):1010-1021. doi: 10.1007/s12328-020-01237-x.)
3. Cheng ML, Zhang L, Borok M, Chokunonga E, Dzamamala C, Korir A, Wabinga HR, Hiatt RA, Parkin DM, Van Loon K. The incidence of oesophageal cancer in Eastern Africa: identification of a new geographic hot spot?. Cancer Epidemiol. 2015;39(2):143-9;
4. Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon, France. Available from: https://gco.iarc.fr/today. Accessed 08 August 2022.
5. Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–48.
6. Lorenzoni C, Vilajeliu A, Carrilho C, et al: Trends in cancer incidence in Maputo, Mozambique,1991-2008. PLoS One 2015; 10: e0130469. DOI: 10.1371/journal.pone.0130469
7. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, et al. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer. 2006; 118:985–90. [PubMed: 16106415];
8. Loots, E., Sartorius, B., Madiba, T. E., Mulder, C. J. J. & Clarke, D. L. 2017. Oesophageal squamous cell cancer in a South African tertiary hospital: a risk factor and presentation analysis. South African Journal of Surgery 55(3): 42–46
9. Kayamba, V., Bateman, A. C., Asombang, A. W., Shibemba, A., Zyambo, K., Banda, T., Soko, R. & Kelly, P. 2015. HIV infection and domestic smoke exposure, but not human papillomavirus, are risk factors for esophageal squamous cell carcinoma in Zambia: A case-control study. Cancer Medicine 4(4): 588–595,
10. Jensen BE, Oette M, Haes J, Häussinger D. HIV-Associated Gastrointestinal Cancer. Oncol Res Treat. 2017;40(3):115-118. doi: 10.1159/000456714
11. Nutor JJ, Duodu PA, Agbadi P, Duah HO, Oladimeji KE, Gondwe KW. Predictors of high HIV+ prevalence in Mozambique: A complex samples logistic regression modeling and spatial mapping approaches. PLoS One. 2020 Jun 4;15(6):e0234034. doi: 10.1371/journal.pone.0234034. Erratum in: PLoS One. 2020 Jun 25;15(6):e0235456. PMID: 32497145; PMCID: PMC7272061.
12. Come J, Castro C, Morais A, Cossa M, Modcoicar P, Tulsidâs S, Cunha L, Lobo V, Morais AG, Cotton S, Lunet N, Carrilho C, Santos LL. Clinical and Pathologic Profiles of Esophageal Cancer in Mozambique: A Study of Consecutive Patients Admitted to Maputo Central Hospital. J Glob Oncol. 2018 Nov;4:1-9. doi: 10.1200/JGO.18.00147.
13. Cunha Lina, Fontes Filipa, Come Jotamo, Lobo Vitória, Santos Lúcio Lara, Lunet Nuno, Carrilho Carla (2022) Risk factors for oesophageal squamous cell carcinoma in Mozambique ecancer 16 1437
14. Thrift AP, Kramer JR, Hartman CM, Royse K, Richardson P, Dong Y, Raychaudhury S, Desiderio R, Sanchez D, Anandasabapathy S, White DL, Chiao EY. Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study. J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):e65-e72. doi: 10.1097/QAI.0000000000002038.).
15. Ranjit S, Kumar S. Recent advances in cancer outcomes in HIV-positive smokers. F1000Res. 2018;7:F1000 Faculty Rev-718. Published 2018 Jun 11. doi:10.12688/f1000research.12068.1
16. McCormack VA, Menya D, Munishi MO, et al.: Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors. Int J Cancer. 2017;140(2):259–71. 10.1002/ijc.30292
17. Moses A, Mwafongo A, Chikasema M, et al.: Risk factors for common cancers among patients at Kamuzu Central Hospital in Lilongwe, Malawi: A retrospective cohort study. Malawi Med J. 2017;29(2):136–41.).
18. Helleberg M, Gerstoft J, Afzal S, et al.: Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS. 2014;28(10):1499–508
19. Park LS, Tate JP, Sigel K, et al.: Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012. AIDS. 2016;30(11):1795–806. 10.1097/QAD.0000000000001112
20. Ana Catarina Luz , Sophia Baumert , Janet Fisher , Isla Grundy , Maria Matediane , Genevieve Patenaude , Natasha Ribeiro, Casey Ryan , Frank Vollmer , Emily Woollen1 , Pedro Zorrilla Charcoal production and trade in southern Mozambique: historical trends and present scenarios XIV WORLD FORESTRY CONGRESS, Durban, South Africa, 7-11 September 2015, DOI: 10.13140/RG.2.1.1677.8729
21. Nutor JJ, Duodu PA, Agbadi P, Duah HO, Oladimeji KE, Gondwe KW (2020) Predictors of high HIV+ prevalence in Mozambique: A complex samples logistic regression modeling and spatial mapping approaches. PLoS ONE 15(6): e0234034. https://doi.org/10.1371/journal.pone.0234034.
22. Wiginton JM, Mathur S, Gottert A, Pilgrim N, Pulerwitz J. Hearing From Men Living With HIV: Experiences With HIV Testing, Treatment, and Viral Load Suppression in Four High-Prevalence Countries in Sub-Saharan Africa. Front Public Health. 2022 May 16;10:861431. doi: 10.3389/fpubh.2022.861431.
23. Coghill AE, Newcomb PA, Madeleine MM, Richardson BA, Mutyaba I, Okuku F, Phipps W, Wabinga H, Orem J, Casper C. Contribution of HIV infection to mortality among cancer patients in Uganda. AIDS. 2013 Nov 28;27(18):2933-42. doi: 10.1097/01. aids.0000433236.55937.cb. PMID: 23921614;
24. Asombang AW, Chishinga N, Nkhoma A, Chipaila J, Nsokolo B, Manda-Mapalo M, Montiero JFG, Banda L, Dua KS. Systematic review and meta-analysis of esophageal cancer in Africa: Epidemiology, risk factors, management and outcomes. World J Gastroenterol. 2019 Aug 21;25(31):4512-4533. doi: 10.3748/wjg.v25.i31.4512
Published
2024-07-29
How to Cite
MORAIS, Atílio et al. HIV And Esophageal Cancer In Mozambique: What Can We Learn?. Revista Portuguesa de Cirurgia, [S.l.], n. 57, p. 93-100, july 2024. ISSN 2183-1165. Available at: <https://revista.spcir.com/index.php/spcir/article/view/1047>. Date accessed: 19 aug. 2024. doi: https://doi.org/10.34635/rpc.1047.
Section
Original Papers